Sotera Health Company (SHC) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $16.09 (-0.83%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 9, 2026 | Jason Bednar | Piper Sandler | $24.00 | +49.1% |
| Jan 8, 2026 | Ryan Halstead | RBC Capital | $24.00 | +49.1% |
| May 5, 2025 | Matthew Sykes | Goldman Sachs | $17.00 | +5.6% |
| Dec 5, 2024 | David Windley | Jefferies | $15.00 | -6.8% |
| Nov 6, 2024 | David Windley | Jefferies | $18.00 | +11.8% |
| Aug 6, 2024 | Luke Sergott | Barclays | $17.00 | +5.6% |
| Jun 6, 2024 | David Windley | Jefferies | $14.50 | -9.9% |
| May 21, 2024 | Jason Bednar | Piper Sandler | $13.00 | -19.2% |
| May 3, 2024 | Sean Dodge | RBC Capital | $17.00 | +5.6% |
| Apr 10, 2024 | Luke Sergott | Barclays | $14.00 | -13.0% |
| Mar 25, 2024 | David Windley | Jefferies | $15.50 | -3.7% |
| Jun 26, 2023 | Matthew Mishan | Loop Capital Markets | $24.00 | +49.1% |
| Jan 10, 2023 | Mike Polark | Wolfe Research | $25.00 | +55.3% |
| Jan 10, 2023 | Luke Sergott | Barclays | $22.00 | +36.7% |
Top Analysts Covering SHC
SHC vs Sector & Market
| Metric | SHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 5 | 8 | 19 |
| Target Upside | +32.5% | +11475.0% | +17.1% |
| P/E Ratio | 39.23 | 3.87 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $313M | $314M | $315M | 6 |
| 2026-09-30 | $321M | $325M | $326M | 4 |
| 2026-12-31 | $325M | $329M | $330M | 5 |
| 2027-03-31 | $283M | $286M | $287M | 3 |
| 2027-06-30 | $331M | $334M | $335M | 3 |
| 2027-09-30 | $340M | $343M | $345M | 3 |
| 2027-12-31 | $347M | $350M | $352M | 3 |
| 2028-12-31 | $1.39B | $1.39B | $1.39B | 4 |
| 2029-12-31 | $1.48B | $1.49B | $1.50B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.24 | $0.25 | $0.25 | 6 |
| 2026-09-30 | $0.27 | $0.27 | $0.27 | 3 |
| 2026-12-31 | $0.27 | $0.27 | $0.27 | 4 |
| 2027-03-31 | $0.19 | $0.20 | $0.20 | 2 |
| 2027-06-30 | $0.26 | $0.27 | $0.27 | 2 |
| 2027-09-30 | $0.29 | $0.29 | $0.29 | 2 |
| 2027-12-31 | $0.30 | $0.30 | $0.30 | 2 |
| 2028-12-31 | $1.07 | $1.16 | $1.24 | 2 |
| 2029-12-31 | $1.28 | $1.29 | $1.30 | 1 |
Frequently Asked Questions
What is the analyst consensus for SHC?
The consensus among 5 analysts covering Sotera Health Company (SHC) is Buy with an average price target of $22.00.
What is the highest price target for SHC?
The highest price target for SHC is $25.00, set by Mike Polark at Wolfe Research on 2023-01-10.
What is the lowest price target for SHC?
The lowest price target for SHC is $13.00, set by Jason Bednar at Piper Sandler on 2024-05-21.
How many analysts cover SHC?
5 analysts have issued ratings for Sotera Health Company in the past 12 months.
Is SHC a buy or sell right now?
Based on 5 analyst ratings, SHC has a consensus rating of Buy (2.00/5) with a +32.5% upside to the consensus target of $22.00.
What are the earnings estimates for SHC?
Analysts estimate SHC will report EPS of $0.25 for the period ending 2026-06-30, with revenue estimated at $314M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.